EUVIMEDObjevte EUVIMED
Crossref

Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study

J Bremer iD, H H Pas, G F H Diercks, H J Meijer, S M van der Molen, A M Nijenhuis, L L van Nijen-Vos, P Morandé, M J Yubero, F Palisson, I Fuentes iD, A M G Pasmooij

Experimental Dermatology · 2024

DOI: 10.1111/exd.15035 ↗

At a glance

Journal article in Experimental Dermatology, 2024. Written by J Bremer and 11 co-authors. Institution: Department of Dermatology, Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Major MEDLINE topics: Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Epidermolysis Bullosa, Junctional, Autoimmune Diseases. Cited 3 times so far (Crossref); 15 references. Funded by: Fondo Nacional de Desarrollo Científico y Tecnológico, ANID, Chile, Fondo Nacional de Desarrollo Científico y Tecnológico.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Epidermolysis bullosa (EB) is a heritable skin blistering disease caused by variants in genes coding for proteins that secure cell–cell adhesion and attachment of the epidermis to the dermis. Interestingly, several proteins involved in inherited EB are also associated with autoimmune blistering diseases (AIBD). In this study, we present a long‐term follow‐up of 15 patients suffering from recessive dystrophic or junctional EB. From these patients, 62 sera were analysed for the presence of autoantibodies associated with AIBD. We show that patients suffering from recessive dystrophic EB (RDEB) are more susceptible to developing autoantibodies against skin proteins than patients suffering from junctional EB (70% vs. 20%, respectively). Interestingly, no correlation with age was observed. Most patients showed reactivity to Type XVII collagen/linear IgA bullous dermatosis autoantigen ( n = 5; 33%), followed by BP230 ( n = 4; 27%), Type VII collagen ( n = 4; 27%) and laminin‐332 ( n = 1; 7%). The pathogenicity of these autoantibodies remains a subject for future experiments.

Subjects

MeSH terms (MEDLINE)

Epidermolysis Bullosa DystrophicaEpidermolysis BullosaEpidermolysis Bullosa, JunctionalAutoimmune DiseasesHumansAutoantibodiesSkin

Author keywords

Type VII collagenautoantibodiesdystrophic epidermolysis bullosajunctional epidermolysis bullosaserological follow-up

Substances

Autoantibodies

Authors and institutions

  • Department of Dermatology, Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • DEBRA Chile, Santiago, Chile.
  • Pediatrics and Pediatric Infectious Diseases of Clínica Alemana, Facultad de Medicina Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Servicio de Dermatología, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.

ORCID profiles: J Bremer, I Fuentes

Funding

  • Fondo Nacional de Desarrollo Científico y Tecnológico, ANID, Chile
  • Fondo Nacional de Desarrollo Científico y Tecnológico

Cite

APA

Bremer, J., Pas, H. H., Diercks, G. F. H., Meijer, H. J., van der Molen, S. M., Nijenhuis, A. M., van Nijen-Vos, L. L., Morandé, P., Yubero, M. J., Palisson, F., Fuentes, I., & Pasmooij, A. M. G. (2024). Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study. Experimental Dermatology. https://doi.org/10.1111/exd.15035

Vancouver

Bremer J, Pas HH, Diercks GFH, Meijer HJ, van der Molen SM, Nijenhuis AM, et al. Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study. Experimental Dermatology. 2024. doi:10.1111/exd.15035

BibTeX
@article{Bremer2024,
  author = {Bremer, J and Pas, H H and Diercks, G F H and Meijer, H J and van der Molen, S M and Nijenhuis, A M and van Nijen-Vos, L L and Morandé, P and Yubero, M J and Palisson, F and Fuentes, I and Pasmooij, A M G},
  title = {Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study},
  journal = {Experimental Dermatology},
  year = {2024},
  doi = {10.1111/exd.15035}
}
Start for free →